Stock Market & Financial Investment News

News Breaks February 27, 2013 08:01 EDT NUVA NuVasive price target raised to $22 from $19 at RW Baird Baird raised its price target on NuVasive following solid Q4 results. The firm cited reasons to expect higher revenue growth on better than expected leverage opportunities. Baird likes the risk/reward and maintains its Outperform rating. News For NUVA From The Last 14 Days Check below for free stories on NUVA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 07:48 EDT NUVA FDA Orthopaedic and Rehabilitation Devices Panel to hold a meeting Subscribe for More Information May 20, 2013 15:53 EDT NUVA NuVasive removed from Best Ideas List at Barrington Barrington removed NuVasive from its Best Ideas List due to recent outperformance but reiterates its Outperform rating. May 17, 2013 10:07 EDT NUVA On The Fly: Analyst Initiation Summary Subscribe for More Information 06:41 EDT NUVA NuVasive initiated with a Buy at WallachBeth Subscribe for More Information May 14, 2013 07:18 EDT NUVA BofA/Merrill to host a conference 2013 Health Care Conference is being held in Las Vegas on May 14-16. Sign up for a free trial to see the rest of the stories you've been missing.